(Q36417684)

English

A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

ChEBI release 2020-05-28

randomized controlled trial

1 reference

based on heuristic

inferred from title

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Dr. Satish S.C. Rao

1

object named as

Satish Rao

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Anthony J Lembo

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Steven J Shiff

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Bernard J Lavins

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Mark G Currie

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Xinwei D Jia

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Kelvin Shi

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

James E MacDougall

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

James Z Shao

9

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Paul Eng

10

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Susan M Fox

11

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Harvey A Schneier

12

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Caroline B Kurtz

13

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Jeffrey M Johnston

14

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

1 November 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

107

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1714-24; quiz p.1725

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

An evidence-based position statement on the management of irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Clinical practice. Irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Functional bowel disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Irritable bowel syndrome: toward an understanding of severity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

The burden of illness of irritable bowel syndrome: current challenges and hope for the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

AGA technical review on irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Functional bowel disorders and functional abdominal pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Stool form scale as a useful guide to intestinal transit time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

30 September 2017

Two randomized trials of linaclotide for chronic constipation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

21 September 2018

Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

21 September 2018

Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

21 September 2018

Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

21 September 2018

Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

21 September 2018

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504311

21 September 2018

Total costs of IBS: employer and managed care perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/AJG.2012.255

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36417684&oldid=1548022667"